We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$76.7B
AUM Growth
+$3.2B
Cap. Flow
-$965M
Cap. Flow %
-1.26%
Top 10 Hldgs %
9.81%
Holding
4,066
New
622
Increased
1,512
Reduced
1,263
Closed
399

Sector Composition

Rank Sector Weight
1 Technology 15.15%
2 Consumer Discretionary 12.62%
3 Healthcare 10.65%
4 Financials 9.26%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVID
3526
DELISTED
Avid Technology Inc
AVID
$177K ﹤0.01%
34,043
+17,922
+111% +$87.5K
XONE
3527
PUT
DELISTED
The ExOne Company
XONE
$177K ﹤0.01%
25,000
CPRX
3528
DELISTED
Catalyst Pharmaceutical
CPRX
$175K ﹤0.01%
56,122
-52,826
-48% -$160K
RNET
3529
DELISTED
RigNet, Inc.
RNET
$175K ﹤0.01%
+16,951
New +$224K
IBRX icon
3530
ImmunityBio
IBRX
$8.26B
$174K ﹤0.01%
56,596
+15,787
+39% +$58.5K
UPL
3531
PUT
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$173K ﹤0.01%
75,000
-5,000
-6% -$12.2K
NOG icon
3532
Northern Oil and Gas
NOG
$2.91B
$165K ﹤0.01%
5,229
+3,059
+141% +$68.9K
CLDX icon
3533
Celldex Therapeutics
CLDX
$3.17B
$163K ﹤0.01%
21,627
-1,439
-6% -$19.2K
RCM
3534
DELISTED
R1 RCM Inc. Common Stock
RCM
$162K ﹤0.01%
+18,681
New +$151K
SSI
3535
DELISTED
Stage Stores Inc
SSI
$161K ﹤0.01%
66,626
-77,498
-54% -$212K
CPL
3536
DELISTED
CPFL Energia S.A.
CPL
$161K ﹤0.01%
14,552
-85
-0.6% -$1.08K
ALTO icon
3537
Alto Ingredients
ALTO
$340M
$160K ﹤0.01%
61,644
+50,611
+459% +$161K
RMTI icon
3538
Rockwell Medical
RMTI
$32.6M
$157K ﹤0.01%
290
-383
-57% -$230K
AMRN
3539
PUT
Amarin Corp
AMRN
$298M
$155K ﹤0.01%
+2,500
New +$155K
PFLT icon
3540
PennantPark Floating Rate Capital
PFLT
$731M
$154K ﹤0.01%
11,240
-1,232
-10% -$16.7K
HABT
3541
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
$150K ﹤0.01%
14,968
-60,393
-80% -$562K
TELL
3542
DELISTED
Tellurian Inc.
TELL
$149K ﹤0.01%
+17,928
New +$179K
LBC
3543
DELISTED
Luther Burbank Corporation Common Stock
LBC
$146K ﹤0.01%
+12,690
New +$156K
CMT icon
3544
Core Molding Technologies
CMT
$231M
$144K ﹤0.01%
+10,087
New +$155K
OOMA icon
3545
Ooma
OOMA
$605M
$142K ﹤0.01%
10,033
-4,008
-29% -$47K
WOW
3546
DELISTED
WideOpenWest
WOW
$142K ﹤0.01%
14,671
-32,394
-69% -$261K
NCMI icon
3547
National CineMedia
NCMI
$239M
$141K ﹤0.01%
1,676
-5,108
-75% -$346K
AREX
3548
DELISTED
Approach Resources Inc.
AREX
$137K ﹤0.01%
56,120
+12,020
+27% +$32.2K
TAHO
3549
DELISTED
Tahoe Resources Inc
TAHO
$137K ﹤0.01%
27,746
-20,941
-43% -$105K
ICL icon
3550
ICL Group
ICL
$7.49B
$136K ﹤0.01%
29,561
+427
+1% +$1.96K

Similar funds

David Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
  • David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
  • David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
  • David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
  • David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
  • David Shaw opened 622 new positions and closed 399 in Q2 2018.
  • David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.

Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.